Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Mol Evol ; 91(2): 225-235, 2023 04.
Artigo em Inglês | MEDLINE | ID: mdl-36869271

RESUMO

Chlorophyllide a oxygenase (CAO) is responsible for converting chlorophyll a to chlorophyll b in a two-step oxygenation reaction. CAO belongs to the family of Rieske-mononuclear iron oxygenases. Although the structure and reaction mechanism of other Rieske monooxygenases have been described, a member of plant Rieske non-heme iron-dependent monooxygenase has not been structurally characterized. The enzymes in this family usually form a trimeric structure and electrons are transferred between the non-heme iron site and the Rieske center of the adjoining subunits. CAO is supposed to form a similar structural arrangement. However, in Mamiellales such as Micromonas and Ostreococcus, CAO is encoded by two genes where non-heme iron site and Rieske cluster localize on the distinct polypeptides. It is not clear if they can form a similar structural organization to achieve the enzymatic activity. In this study, the tertiary structures of CAO from the model plant Arabidopsis thaliana and the Prasinophyte Micromonas pusilla were predicted by deep learning-based methods, followed by energy minimization and subsequent stereochemical quality assessment of the predicted models. Furthermore, the chlorophyll a binding cavity and the interaction of ferredoxin, which is the electron donor, on the surface of Micromonas CAO were predicted. The electron transfer pathway was predicted in Micromonas CAO and the overall structure of the CAO active site was conserved even though it forms a heterodimeric complex. The structures presented in this study will serve as a basis for understanding the reaction mechanism and regulation of the plant monooxygenase family to which CAO belongs.


Assuntos
Arabidopsis , Clorofilídeos , Clorófitas , Clorofilídeos/metabolismo , Clorofila A/metabolismo , Oxigenases/genética , Oxigenases/química , Oxigenases/metabolismo , Arabidopsis/genética , Arabidopsis/metabolismo , Oxigenases de Função Mista/metabolismo , Plantas , Clorófitas/metabolismo , Ferro/metabolismo
3.
Plant Physiol ; 173(4): 2138-2147, 2017 04.
Artigo em Inglês | MEDLINE | ID: mdl-28235890

RESUMO

Chlorophyll degradation plays important roles in leaf senescence including regulation of degradation of chlorophyll-binding proteins. Although most genes encoding enzymes of the chlorophyll degradation pathway have been identified, the regulation of their activity has not been fully understood. Green cotyledon mutants in legume are stay-green mutants, in which chlorophyll degradation is impaired during leaf senescence and seed maturation. Among them, the soybean (Glycine max) green cotyledon gene cytG is unique because it is maternally inherited. To isolate cytG, we extensively sequenced the soybean chloroplast genome, and detected a 5-bp insertion causing a frame-shift in psbM, which encodes one of the small subunits of photosystem II. Mutant tobacco plants (Nicotiana tabacum) with a disrupted psbM generated using a chloroplast transformation technique had green senescent leaves, confirming that cytG encodes PsbM. The phenotype of cytG was very similar to that of mutant of chlorophyll b reductase catalyzing the first step of chlorophyll b degradation. In fact, chlorophyll b-degrading activity in dark-grown cytG and psbM-knockout seedlings was significantly lower than that of wild-type plants. Our results suggest that PsbM is a unique protein linking photosynthesis in presenescent leaves with chlorophyll degradation during leaf senescence and seed maturation. Additionally, we discuss the origin of cytG, which may have been selected during domestication of soybean.


Assuntos
Cotilédone/genética , Glycine max/genética , Complexo de Proteína do Fotossistema II/genética , Proteínas de Plantas/genética , Oxirredutases do Álcool/genética , Oxirredutases do Álcool/metabolismo , Sequência de Bases , Biocatálise , Western Blotting , Clorofila/metabolismo , Cloroplastos/genética , Cloroplastos/metabolismo , Cloroplastos/ultraestrutura , Cotilédone/metabolismo , Escuridão , Regulação da Expressão Gênica de Plantas , Microscopia Eletrônica de Transmissão , Mutação , Fenótipo , Complexo de Proteína do Fotossistema II/metabolismo , Folhas de Planta/genética , Folhas de Planta/metabolismo , Proteínas de Plantas/metabolismo , Subunidades Proteicas/genética , Subunidades Proteicas/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Homologia de Sequência do Ácido Nucleico , Glycine max/metabolismo
4.
J Enzyme Inhib Med Chem ; 24(1): 279-86, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18830882

RESUMO

Cathepsins B and L belong to the papain superfamily of cysteine proteases and play important roles in various physiological and pathological processes. In the course of studies on their inhibitors, we examined the inhibitory effects of the peptide aldehyde benzyloxycarbonyl-leucyl-leucyl-leucinal (ZLLLal) and its analogues. As a result, rat liver cathepsins B and L were shown to be strongly inhibited by them. The concentration required for 50% inhibition (IC(50)) by ZLLLal was 88 nM for cathepsin B and 163 nM for cathepsin L. Moreover, various analogues of ZLLLal, including 2-furancarbonyl-, nicotinyl-, isonicotinyl- and 4-morpholinylsuccinyl-LLLals, and some acetyl-Pro (AcP)-containing analogues, AcPLLLal and AcPPLLLal, were shown to inhibit both enzymes more strongly than ZLLLal. Among them, isonicotinyl-LLLal was most inhibitory against both cathepsins B (IC(50), 12 nM) and L (IC(50), 20 nM). Several of these inhibitors were indicated to be somewhat more soluble in aqueous media than ZLLLal.


Assuntos
Catepsina B/antagonistas & inibidores , Catepsinas/antagonistas & inibidores , Leupeptinas/farmacologia , Animais , Catepsina L , Cisteína Endopeptidases , Relação Dose-Resposta a Droga , Concentração Inibidora 50 , Ratos
5.
Artigo em Inglês | MEDLINE | ID: mdl-18786647

RESUMO

The amino acid sequences of three pepsinogens (PG1, PG2 and PG3) of Pacific bluefin tuna (Thunnus orientalis) were deduced by cloning and nucleotide sequencing of the corresponding cDNAs. The amino acid sequences of the pre-forms of PG1, PG2 and PG3 were composed of a signal peptide (16 residues each), a propeptide (41, 37 and 35 residues, respectively) and a pepsin moiety (321, 323 and 332 residues, respectively). Amino acid sequence comparison and phylogenetic analysis indicated that PG1 and PG2 belong to the pepsinogen A family and PG3 to the pepsinogen C family. Homology modeling of the three-dimensional structure suggested that the remarkably high specific activity of PG2 toward hemoglobin, which had been found previously, was partly due to a characteristic deletion of several residues in the S1'-loop region that widens the space of the active site cleft region so as to accommodate protein and larger polypeptide substrates more efficiently. Including the tuna and all other fish pepsinogen sequences available to date, the molecular phylogenetic comparison was made with reference to evolution of fish pepsinogens. It was suggested that functional divergences of pepsinogens (pepsins) occurring in fishes as well as in mammals, correlated with differences in various aspects of fish physiology.


Assuntos
Evolução Molecular , Pepsinogênios/química , Pepsinogênios/genética , Filogenia , Sequência de Aminoácidos , Animais , Sequência de Bases , Clonagem Molecular , DNA Complementar/genética , Dados de Sequência Molecular , Sinais Direcionadores de Proteínas , Homologia Estrutural de Proteína , Atum
6.
J Enzyme Inhib Med Chem ; 23(3): 352-6, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18569339

RESUMO

1,2-Epoxy-3-(p-nitrophenoxy)propane (EPNP) is known to inhibit pepsin A and other aspartic proteinases by reacting with the active site aspartic acid residue(s). However, the reaction is considerably slow in general, and therefore, it is desirable to develop similar reagents that are capable of inhibiting these enzymes more rapidly. In the present study, we synthesized a series of novel inhibitors which have a reactive epoxide group linked with peptide by a hydrazide bond, with a general structure: Iva-L-Val-L-Val-(L-AA)(n)-N2H2-ES-OEt (n = 0 approximately 2) (Iva, isovaleryl; AA, bulky hydrophobic or aromatic amino acid residue; ES, epoxysuccinyl). These inhibitors were shown to inhibit porcine pepsin A remarkably faster than EPNP.


Assuntos
Compostos de Epóxi/farmacologia , Pepsina A/antagonistas & inibidores , Peptídeos/farmacologia , Inibidores de Proteases/química , Animais , Compostos de Epóxi/química , Estrutura Molecular , Peptídeos/química , Inibidores de Proteases/farmacologia , Relação Estrutura-Atividade , Suínos
7.
Biosci Biotechnol Biochem ; 72(3): 905-8, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18323639

RESUMO

The substrate specificities of porcine and bovine enteropeptidases were investigated using the peptide Val-(Asp)(4)-Lys-Ile-Val-Gly and its various analogs with mutations in the (Asp)(4)-Lys sequence as substrates. The results indicated that in addition to P1 Lys, P2 Asp in the substrates is most important, that P3 Asp is additionally important, and that P5 Asp contributes somewhat to the susceptibility, and that P4 Asp is the least important. These results were essentially identical as between porcine and bovine enteropeptidases.


Assuntos
Enteropeptidase/metabolismo , Peptídeos/metabolismo , Sequência de Aminoácidos , Animais , Bovinos , Mutação , Peptídeos/síntese química , Relação Estrutura-Atividade , Especificidade por Substrato , Suínos
8.
Rinsho Shinkeigaku ; 45(5): 380-2, 2005 May.
Artigo em Japonês | MEDLINE | ID: mdl-15960177

RESUMO

A 30 year-old man with CFTD was reported. He had normal motor milestone during infancy but had been poor at sports. At 28, he experienced exertional and nocturnal dyspnea and had been diagnosed as having dilated cardiomyopathy. At 29, a cardiac pace-maker was implanted because of the complete atrio-ventricular block. Around that time, he began to notice limb muscle weakness. Examination at 30 showed mild diffuse muscle atrophy and weakness at the torso and limbs. No dysmorphic features or joint contractures were noted. His serum CK was normal. A histochemical study of his muscle biopsy showed type 1 fiber predominancy (64.6%) and that the mean diameter of type 1 fibers was smaller than that of type 2 by 14.6% (36.9 microm vs. 42.3 microm). Results of immunostaining of dystrophin, emerin, laminA/C, alpha, beta, gamma, delta-sarcoglycan or dysferlin were normal. He was diagnosed as having CFTD because there were no histochemical abnormalities which characterize other congenital myopathies except for the type 1 predominancy and atrophy.


Assuntos
Cardiomiopatias/etiologia , Miopatias Congênitas Estruturais/complicações , Adulto , Insuficiência Cardíaca/etiologia , Humanos , Masculino
9.
Cell Mol Neurobiol ; 24(1): 37-50, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15049509

RESUMO

Mastoparan (MP), a tetradecapeptide in wasp venom, has been reported to evoke catecholamine release, but also reported to inhibit secretory response upon nicotinic stimulation in adrenal chromaffin cells. To elucidate the inhibitory mechanism of MP, we examined the effect of two MP fragments (INLK-NH2 and KKIL-NH2) on catecholamine release in bovine adrenal chromaffin cells. These MP fragments inhibited catecholamine release induced by nicotinic stimulation in a noncompetitive manner. These fragments did not affect catecholamine release evoked by high [K+] or by other secretagogues, neither caused catecholamine release by themselves. Replacement by hydrophobic and basic amino acids of the MP fragments enhanced the inhibitory effects on ACh-evoked catecholamine release. Among 23 analogs of the MP fragments, (Nle)3-R-NH2 showed the most potent inhibition with IC50 = 541 microM. These results suggested that the MP fragments selectively inhibit the secretory response to nicotinic stimulation by attacking nAChR on the site(s) made up of hydrophobic and acidic amino acids but other than ACh-binding sites. This mechanism may explain the inhibitory action of MP on nicotine-evoked catecholamine release.


Assuntos
Medula Suprarrenal/efeitos dos fármacos , Catecolaminas/metabolismo , Células Cromafins/efeitos dos fármacos , Fragmentos de Peptídeos/farmacologia , Receptores Nicotínicos/efeitos dos fármacos , Venenos de Vespas/farmacologia , Medula Suprarrenal/metabolismo , Aminoácidos/química , Aminoácidos/fisiologia , Animais , Sítios de Ligação/efeitos dos fármacos , Sítios de Ligação/fisiologia , Bovinos , Células Cultivadas , Células Cromafins/metabolismo , Interações Hidrofóbicas e Hidrofílicas , Peptídeos e Proteínas de Sinalização Intercelular , Antagonistas Nicotínicos/química , Antagonistas Nicotínicos/farmacologia , Fragmentos de Peptídeos/química , Peptídeos , Potássio/metabolismo , Potássio/farmacologia , Estrutura Terciária de Proteína/fisiologia , Receptores Nicotínicos/metabolismo , Venenos de Vespas/química
10.
Plant Cell Physiol ; 44(7): 655-60, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12881492

RESUMO

GSH has multiple actions in physiological responses of plants, but the molecular mechanisms are not fully understood. GSH plays an important role in functional alteration of proteins by reversible covalent incorporation (glutathionylation) in vertebrate cells. To investigate the function of glutathionylation in plant cells, we examined glutathionylated proteins in the suspension-cultured cells of Arabidopsis using biotinylated GSH. Biotinylated GSH was incorporated into about 20 proteins. Two of these proteins were identified as the key enzymes for sugar metabolism, triose-phosphate isomerase (TPI) and putative plastidic aldolase. Recombinant TPI was inactivated by GSSG, and it was reactivated by GSH. The physiological roles of glutathionylation of TPI and aldolase in sugar metabolism are discussed.


Assuntos
Aldeído Liases/metabolismo , Arabidopsis/metabolismo , Metabolismo dos Carboidratos , Glutationa/metabolismo , Triose-Fosfato Isomerase/metabolismo , Aldeído Liases/genética , Arabidopsis/genética , Proteínas de Arabidopsis/efeitos dos fármacos , Proteínas de Arabidopsis/metabolismo , Biotinilação/métodos , Oxirredução , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Triose-Fosfato Isomerase/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA